Two thirds of countries have yet to meet the target of vaccinating 70 percent of people in all countries against COVID-19 set a year ago at the UN General Assembly, according to figures published today by Oxfam and The People’s Vaccine Alliance.
The campaign groups said there had been a massive failure to deliver on the promise despite President Biden persuading world leaders to commit to meeting the World Health Organization (WHO) target. Oxfam and The People’s Vaccine Alliance are calling for leaders to radically shift their approach for the current and future pandemics by prioritizing sustainable, local manufacturing in all regions of the world to ensure developing countries get equal access to vaccines, tests and treatments. They said the continued approach of leaving Big Pharma in charge of the response has prolonged the pandemic for all of us and continues to cause havoc the world cannot afford.
“This massive failure to meet promises to protect the world from COVID-19 is indefensible. While the end of the pandemic should be in sight, hundreds of millions of people in developing countries are still unprotected from COVID-19. We are calling on President Biden and other world leaders not to turn their backs on them while the virus continues to kill and cause devastation to people’s livelihoods,” said Anna Marriott, Oxfam’s Health Policy Manager.
The death toll from COVID-19 is four times higher in lower-income countries, where less than half (48 percent) the population have had their full initial round of vaccinations. At the current rate, it will take almost two and a half years for 70 percent of people in the poorest countries to be fully vaccinated. Meanwhile rich countries are already beginning to rollout booster programs, and in some cases fifth shots, using the new generation vaccines, the majority of which have been ordered by rich nations.
At the same time, Pfizer/BioNTech and Moderna are continuing to reap huge profits while refusing to work with the WHO to share their vaccine technology, despite it being funded by public money.
“It is time to radically redesign a system that puts pharma profits ahead of people’s lives,” continued Marriott. “Developing countries need access to vaccines, tests and treatments at the same time as rich countries, not years later after people have died. We are seeing the same deadly inequality for COVID-19 treatments and now for monkeypox vaccines, governments must not allow this to continue.”
Lack of vaccination means the need for COVID-19 tests and treatments is even greater in poorer nations but inequality in access is even starker, yet rich nations are at this moment fiercely resisting any attempt to extend the WTO agreement on vaccines to tests and treatments. Reports from the ACT-Accelerator indicated that almost no doses of any outpatient antivirals are available in low- and middle-income countries.
The campaign groups said this persistent gap demonstrates the massive failings in the international response to COVID-19, which continually ignored the need to diversify manufacturing so that developing countries could make their own doses and manage their own supply concurrently with deliveries to rich countries. They are calling for leaders to:
- Implement an immediate extension of the June 2022 WTO decision on COVID-19 vaccine patents to include tests and treatments – there can be no justification for delay.
- Support and protect the WH- led mRNA technology transfer hub, including demanding Moderna withdraw patents in South Africa and ensure the hub has freedom to develop COVID-19 and other life-saving vaccines now and into the future.
- Deliver a Pandemic Treaty that delivers life-saving vaccines, tests and treatments as global public goods, free of the monopoly control of pharmaceutical corporations.
- Commit to an unprecedented scale up of financing to strengthen country health systems in low and middle-income countries and global funding support to close the vaccination coverage gaps for low- and middle-income countries that have yet to hit the 70 per cent target.
- Reject Big Pharma led proposals – the so-called Berlin Declaration - which would leave full control of who lives and who dies in their hands.
A recent report found that a combination of unpredictable vaccine supplies, lack of antiviral treatments and poor funding for health systems led to lower vaccination rates in developing countries, and that vaccine hesitancy was being used as an excuse to mask the international failures in the COVID-19 response.
“Everyone everywhere should have access to the tools needed to fight a pandemic, But COVID-19 has been a case of survival of the richest. For most of this pandemic, big pharmaceutical companies left people in developing countries to die without vaccines and treatments while they sold doses to rich governments in the global north,” said Maaza Seyoum, Global South Convenor of the People’s Vaccine Alliance. “Now, big pharma is trying to rewrite history, claiming that the industry will voluntarily ensure global access to medicines in the next pandemic. We know from COVID-19 that this isn’t true. Governments cannot rely on the good will of pandemic profiteers to do the right thing. We need to overhaul this system to put human life before private profit.”
The People’s Vaccine Alliance, a coalition of over 100 organizations, have distributed posters across New York, host of the UN General Assembly, describing the COVID-19 pandemic as “survival of the richest”.
Data sourced from Our World in Data on September 14, 2022:
- A search of the 194 members of the WHO on Our World in Data found that 60 countries have reached the 70% target, 129 are below and 5 have not reported any data.
- The rate of people being fully vaccinated is based on the number of people who were reported as fully vaccinated between 07/06/2022 and 04/09/2022 - 37,253,644 people or 418,580 per day on average. 70% of the population of low-income countries, minus those who have already been fully vaccinated is, 368,878,851. Dividing this figure by the daily average rate of vaccination gives 881 days until the target is reached. This figure does include Rwanda who are the only low-income country to have already reached the 70% target, but it is not possible to exclude them from the dataset we are using – the difference including them makes to the overall figure is negligible though.